Controlling persister cells of Pseudomonas aeruginosa PDO300 by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one

Bioorg Med Chem Lett. 2013 Aug 15;23(16):4648-51. doi: 10.1016/j.bmcl.2013.06.011. Epub 2013 Jun 13.

Abstract

Pseudomonas aeruginosa is a major pathogen causing chronic pulmonary infections; for example, 80% of cystic fibrosis patients get infected by this bacterium as the disease progresses. Such chronic infections are challenging because P. aeruginosa exhibits high-level tolerance to antibiotics by forming biofilms (multicellular structures attached to surfaces), by entering dormancy and forming antibiotic tolerant persister cells, and by conversion to the mucoid phenotype. Recently, we reported that a synthetic quorum sensing inhibitor, (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one (BF8), can sensitize both planktonic and biofilm-associated persister cells of P. aeruginosa PAO1 to antibiotics at the concentrations non-inhibitory to its growth. In this study, we further characterized the effects of this compound on the mucoid strain P. aeruginosa PDO300. BF8 was found to reduce persistence during the growth of PDO300 and effectively kill the persister cells isolated from PDO300 cultures. In addition to planktonic cells, BF8 was also found to inhibit biofilm formation of PDO300 and reduce associated persistence. These findings broaden the activities of this class of compounds and indicate that BF8 also has other targets in P. aeruginosa in addition to quorum sensing.

Keywords: Antibiotic tolerance; Biofilm; Mucoid; Persister; Pseudomonas aeruginosa; Quorum sensing.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 4-Butyrolactone / analogs & derivatives*
  • 4-Butyrolactone / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Biofilms / drug effects
  • Drug Tolerance
  • Molecular Structure
  • Pseudomonas aeruginosa / drug effects*
  • Quorum Sensing / drug effects

Substances

  • 4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one
  • Anti-Bacterial Agents
  • 4-Butyrolactone